Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Out-Of-Pocket Cost For Individuals Being Treated For Opioid Dependence In Rutland County, Vermont, Christopher T. Veal
Out-Of-Pocket Cost For Individuals Being Treated For Opioid Dependence In Rutland County, Vermont, Christopher T. Veal
Family Medicine Clerkship Student Projects
Each day more than 140 Americans die from drug overdoses, 91 specifically due to opioids. In Vermont, more than 50 people die each year from opioid poisoning. With insurance coverage being a critical component of Opioid Dependence Recovery, many people seeking treatment are unaware of the financial barriers to recovery- namely the out-of-pocket costs associated with treatment. This study sought to provide insight on the financial impact of Opioid Dependence Treatment on the patient, and provide financial assistance information to the Rutland County community.
Introducing Opiate Addicts To The Hub And Spoke Treatment System In Vermont, Richard T. Carrick
Introducing Opiate Addicts To The Hub And Spoke Treatment System In Vermont, Richard T. Carrick
Family Medicine Clerkship Student Projects
Opiate abuse and addiction is an epidemic in the state of Vermont. Brandon Medical Center has recently become involved in Vermont's "Hub and Spoke" system of medically assisted opiate addiction treatment. This project involved the development of a pamphlet for safe, low-threshold transmission of information regarding opiate addiction and entrance into this system for patient's who may be suffering from this disease.
Barriers To Recovery For Bangor's Buprenorphine Patients, John R. Mclaren, Erin Keller
Barriers To Recovery For Bangor's Buprenorphine Patients, John R. Mclaren, Erin Keller
Family Medicine Clerkship Student Projects
There are several buprenorphine providers at EMMc's Center for Family Medicine serving the greater Bangor, ME region - an area of substantial opiate use. Among the patient population of outpatient buprenorphine users, both locally and nationally, there are high rates of relapse (~32%). In order to decrease relapse rates, it's first imperative to conduct a baseline review of the current buprenorphine population to identify specific types of patients who are at higher risk of relapse. By understanding the barriers to recovery, the office hopes to apply an intervention to the current program, targeting this local demographic more effectively.